• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

FGIN-1-27,一种 18kDa 膜转运蛋白(TSPO)激动剂,在非哺乳动物模型中产生抗焦虑和抗惊恐作用。

FGIN-1-27, an agonist at translocator protein 18 kDa (TSPO), produces anti-anxiety and anti-panic effects in non-mammalian models.

机构信息

Laboratório de Neurofarmacologia e Biofísica, Departamento de Morfologia e Ciências Fisiológicas, Universidade do Estado do Pará - Campus VIII, Marabá, Brazil.

Laboratorio de Neurofarmacología, Instituto de Neuroetología, Universidad Veracruzana, Xalapa, Mexico.

出版信息

Pharmacol Biochem Behav. 2018 Aug;171:66-73. doi: 10.1016/j.pbb.2018.04.007. Epub 2018 Apr 24.

DOI:10.1016/j.pbb.2018.04.007
PMID:29698632
Abstract

FGIN-1-27 is an agonist at the translocator protein 18 kDa (TSPO), a cholesterol transporter that is associated with neurosteroidogenesis. This protein has been identified as a peripheral binding site for benzodiazepines; in anamniotes, however, a second TSPO isoform that is absent in amniotes has been implicated in erythropoiesis. Functional conservation of the central benzodiazepine-binding site located in the GABA receptors has been demonstrated in anamniotes and amniotes alike; however, it was not previously demonstrated for TSPO. The present investigation explored the behavioral effects of FGIN-1-27 on an anxiety test in zebrafish (Danio rerio, Family: Cyprinide) and on a mixed anxiety/panic test on wall lizards (Tropidurus oreadicus, Family: Tropiduridae). Results showed that FGIN-1-27 reduced anxiety-like behavior in the zebrafish light/dark preference test similar to diazepam, but with fewer sedative effects. Similarly, FGIN-1-27 also reduced anxiety- and fear-like behaviors in the defense test battery in wall lizards, again producing fewer sedative-like effects than diazepam; the benzodiazepine was also unable to reduce fear-like behaviors in this species. These results A) underline the functional conservation of TSPO in defensive behavior in anamniotes; B) strengthen the proposal of using anamniote behavior as models in behavioral pharmacology; and C) suggest TSPO/neurosteroidogenesis as a target in treating anxiety disorders.

摘要

FGIN-1-27 是 18kDa 转位蛋白(TSPO)的激动剂,TSPO 是一种与神经甾体生成有关的胆固醇转运蛋白。这种蛋白已被确定为苯二氮䓬类药物的外周结合位点;然而,在无羊膜动物中,另一种在羊膜动物中不存在的 TSPO 同工型已被牵连到红细胞生成中。中央苯二氮䓬结合位点的功能保守性在无羊膜动物和羊膜动物中都得到了证明;然而,之前并没有在 TSPO 中得到证明。本研究探讨了 FGIN-1-27 在斑马鱼(Danio rerio,Cyprinide 科)焦虑测试和壁蜥(Tropidurus oreadicus,Tropiduridae 科)混合焦虑/惊恐测试中的行为效应。结果表明,FGIN-1-27 减少了斑马鱼光/暗偏好测试中的焦虑样行为,类似于地西泮,但镇静作用较少。同样,FGIN-1-27 也减少了壁蜥防御测试中的焦虑和恐惧样行为,再次产生的镇静样作用比地西泮少;苯二氮䓬类药物也不能减少该物种的恐惧样行为。这些结果 A)强调了 TSPO 在无羊膜动物防御行为中的功能保守性;B)加强了使用无羊膜动物行为作为行为药理学模型的建议;C)提示 TSPO/神经甾体生成作为治疗焦虑障碍的靶点。

相似文献

1
FGIN-1-27, an agonist at translocator protein 18 kDa (TSPO), produces anti-anxiety and anti-panic effects in non-mammalian models.FGIN-1-27,一种 18kDa 膜转运蛋白(TSPO)激动剂,在非哺乳动物模型中产生抗焦虑和抗惊恐作用。
Pharmacol Biochem Behav. 2018 Aug;171:66-73. doi: 10.1016/j.pbb.2018.04.007. Epub 2018 Apr 24.
2
Participation of mitochondrial diazepam binding inhibitor receptors in the anticonflict, antineophobic and anticonvulsant action of 2-aryl-3-indoleacetamide and imidazopyridine derivatives.线粒体地西泮结合抑制因子受体参与2-芳基-3-吲哚乙酰胺和咪唑并吡啶衍生物的抗冲突、抗恐和抗惊厥作用。
J Pharmacol Exp Ther. 1993 May;265(2):649-56.
3
Synthesis and preliminary behavioural evaluation in mice of new 3-aryl-3-pyrrol-1-ylpropanamides, analogues of FGIN-1-27 and FGIN-1-43.新型3-芳基-3-吡咯-1-基丙酰胺(FGIN-1-27和FGIN-1-43的类似物)的合成及其在小鼠中的初步行为学评价
J Pharm Pharmacol. 2001 Nov;53(11):1561-8. doi: 10.1211/0022357011777945.
4
Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.反复给予 18 kDa 转位蛋白配体 AC-5216 可改善创伤后应激障碍小鼠模型的行为缺陷。
Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:40-6. doi: 10.1016/j.pnpbp.2013.04.010. Epub 2013 Apr 23.
5
Translocator protein ligands as promising therapeutic tools for anxiety disorders.转运蛋白配体有望成为治疗焦虑症的有效工具。
Curr Med Chem. 2009;16(26):3359-80. doi: 10.2174/092986709789057653. Epub 2009 Sep 1.
6
Diazepam fails to alter anxiety-like responses but affects motor function in a white-black test paradigm in larval zebrafish (Danio rerio).地西泮未能改变斑马鱼幼虫(Danio rerio)在黑白测试范式中的类似焦虑的反应,但影响了其运动功能。
Prog Neuropsychopharmacol Biol Psychiatry. 2018 Apr 20;83:127-136. doi: 10.1016/j.pnpbp.2018.01.012. Epub 2018 Jan 31.
7
The 18-kDa translocator protein, formerly known as the peripheral-type benzodiazepine receptor, confers proapoptotic and antineoplastic effects in a human colorectal cancer cell line.18 kDa转位蛋白,以前称为外周型苯二氮䓬受体,在人结肠癌细胞系中具有促凋亡和抗肿瘤作用。
Pharmacogenet Genomics. 2008 Nov;18(11):977-88. doi: 10.1097/FPC.0b013e3283117d52.
8
Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).YL-IPA08(一种转运蛋白(18 kDa)的强效配体)的抗抑郁样和抗焦虑样作用
Neuropharmacology. 2014 Jun;81:116-25. doi: 10.1016/j.neuropharm.2013.09.016. Epub 2013 Sep 22.
9
Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.增强神经甾体合成——与转位蛋白(18 kDa)(TSPO)配体及苯二氮䓬类药物药理学的关系
Pharmacopsychiatry. 2015 Mar;48(2):72-7. doi: 10.1055/s-0034-1398507. Epub 2015 Feb 5.
10
Anxiolytic Drug FGIN-1-27 Ameliorates Autoimmunity by Metabolic Reprogramming of Pathogenic Th17 Cells.抗焦虑药物 FGIN-1-27 通过代谢重编程致病性 Th17 细胞改善自身免疫。
Sci Rep. 2020 Feb 28;10(1):3766. doi: 10.1038/s41598-020-60610-5.

引用本文的文献

1
Current advances in the structure-activity relationship (SAR) analysis of the old/new 18-kDa translocator protein ligands.新旧18 kDa转位蛋白配体的构效关系(SAR)分析的当前进展
Mol Divers. 2025 Jun;29(3):2639-2689. doi: 10.1007/s11030-024-10963-0. Epub 2024 Dec 4.
2
Translocator protein in the rise and fall of central nervous system neurons.中枢神经系统神经元兴衰过程中的转位蛋白
Front Cell Neurosci. 2023 Jun 21;17:1210205. doi: 10.3389/fncel.2023.1210205. eCollection 2023.
3
FGIN-1-27 Inhibits Melanogenesis by Regulating Protein Kinase A/cAMP-Responsive Element-Binding, Protein Kinase C-β, and Mitogen-Activated Protein Kinase Pathways.
FGIN-1-27通过调节蛋白激酶A/环磷酸腺苷反应元件结合蛋白、蛋白激酶C-β和丝裂原活化蛋白激酶途径抑制黑色素生成。
Front Pharmacol. 2020 Dec 3;11:602889. doi: 10.3389/fphar.2020.602889. eCollection 2020.
4
Regulation of Anxiety and Depression by Mitochondrial Translocator Protein-Mediated Steroidogenesis: the Role of Neurons.线粒体转位蛋白介导的类固醇生成对焦虑和抑郁的调节:神经元的作用。
Mol Neurobiol. 2021 Feb;58(2):550-563. doi: 10.1007/s12035-020-02136-5. Epub 2020 Sep 29.
5
Anxiolytic Drug FGIN-1-27 Ameliorates Autoimmunity by Metabolic Reprogramming of Pathogenic Th17 Cells.抗焦虑药物 FGIN-1-27 通过代谢重编程致病性 Th17 细胞改善自身免疫。
Sci Rep. 2020 Feb 28;10(1):3766. doi: 10.1038/s41598-020-60610-5.